Reduce costs | Increase value | Enable innovation
Maximizing health care value happens when you improve care, enhance patient experience, and reduce unnecessary costs.
The UCSF Health FY18 Value Improvement Awards
Read more: https://healthvalue.ucsf.edu/ucsf-health-fy18-value-improvement-awards
Cervical Cancer Screening—Moving From the Value
of Evidence to the Evidence
of Value
George F. Sawaya, MD, UCSF
JAMA Intern Medicine
Published online August 21, 2018
Widespread implementation of cytology-based screening programs has resulted in marked declines in cervical cancer incidence and mortality in the United States. Nonetheless, an estimated 13 240 women will be diagnosed with cervical cancer in 2018, and 4170 will die from the disease. It is likely that a sizable proportion of these women will not have been appropriately screened.
Read more:
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2697768
High Value Care Seminar Series, 2018
Sponsored by the UCSF Center for Healthcare Value
View Video Series here
Featured stories:
More Access to HealthCare: Opportunities for Leadership in Value, Quality, and Equity.
Claire Brindis DrPH, Director, Philip R. Lee Institute for Health Policy Studies at UCSF
San Francisco Marin Medicine, March 2018 Read more
Amazon, Buffett, JPMorgan Join Forces on Health Care
Soaring Drug Prices: How They Impact Consumers and What Can Be Done
Drug prices in the United States are twice what they are in the United Kingdom and are much higher than in all other developed countries. In addition, drug prices are rising faster than prices for general consumer products or even other health care products. In this panel, Lisa Gill from Consumer Reports will describe the impact on patients. R. Adams Dudley, MD, from UCSF, will describe the consequences of high or expensive drug costs on patients with severe or chronic health conditions. Finally, Robin Feldman from UC Hastings will outline the role of patent law and market forces in driving prices higher. The panel and the audience will then discuss policy options to address high drug prices.
Video: UCSF Presentation by Lisa Gill and R. Adams Dudley, MD
Video: Capitol Insights: A UC Center Sacramento Panel Discussion
Effect of professional society recommendations on women's desire for a routine pelvic examination
One group of doctors, represented by the American College of Obstetricians and Gynecologists, recommends yearly pelvic exams for all women 21 years of age and older, whether they have symptoms of disease or not.
But the American College of Physicians, representing doctors of internal medicine, says that potential harms of the exam outweigh benefits and recommends against performing pelvic examinations unless a woman is pregnant or has symptoms of disease such as bleeding, pain or signs of infection.
